Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1794)
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
21
Price
$19.00
Total Value
$399.00
Shares Held After
1,158,923
% of Holdings
0.0%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
1
Price
$19.00
Total Value
$19.00
Shares Held After
8,511
% of Holdings
0.0%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
52
Price
$19.00
Total Value
$988.00
Shares Held After
4,939,437
% of Holdings
0.0%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
26
Price
$19.00
Total Value
$494.00
Shares Held After
1,577,406
% of Holdings
0.0%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
47,082
Price
$18.38
Total Value
$865.37K
Shares Held After
1,158,944
% of Holdings
3.9%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
1,170
Price
$18.38
Total Value
$21.50K
Shares Held After
8,512
% of Holdings
12.1%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
119,115
Price
$18.38
Total Value
$2.19M
Shares Held After
4,939,489
% of Holdings
2.4%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
59,870
Price
$18.38
Total Value
$1.10M
Shares Held After
1,577,432
% of Holdings
3.7%
Relay Therapeutics, Inc. (RLAY)
Rahmer Peter — Chief Corporate Development Officer
Shares
753
Price
$14.79
Total Value
$11.14K
Shares Held After
275,857
% of Holdings
0.3%
SANUWAVE Health, Inc. (SNWV)
Opaleye Management Inc. — 10% Owner
Shares
2,500
Price
$18.47
Total Value
$46.17K
Shares Held After
7,500
% of Holdings
25.0%
BRIGHT MINDS BIOSCIENCES INC. (DRUG)
Cormorant Asset Management, LP — Former 10% Owner
Shares
109,331
Price
$89.50
Total Value
$9.79M
Shares Held After
950,000
% of Holdings
10.3%
SANUWAVE Health, Inc. (SNWV)
Opaleye Management Inc. — 10% Owner
Shares
43,788
Price
$18.47
Total Value
$808.65K
Shares Held After
911,010
% of Holdings
4.6%
Relay Therapeutics, Inc. (RLAY)
Bergstrom Donald A — President, R&D
Shares
1,490
Price
$14.79
Total Value
$22.04K
Shares Held After
418,557
% of Holdings
0.4%
Relay Therapeutics, Inc. (RLAY)
Catinazzo Thomas — Chief Financial Officer
Shares
972
Price
$14.79
Total Value
$14.38K
Shares Held After
212,895
% of Holdings
0.5%
IONIS PHARMACEUTICALS INC (IONS)
Baroldi Joseph — EVP, Chief Business Officer
Shares
1,626
Price
$71.79
Total Value
$116.73K
Shares Held After
44,909
% of Holdings
3.5%
Tempus AI, Inc. (TEM)
LEFKOFSKY ERIC P — Director
Shares
27,570
Price
$51.52
Total Value
$1.42M
Shares Held After
15,656,469
% of Holdings
0.2%
Tempus AI, Inc. (TEM)
LEFKOFSKY ERIC P — Director
Shares
105,430
Price
$51.03
Total Value
$5.38M
Shares Held After
15,684,039
% of Holdings
0.7%
Tempus AI, Inc. (TEM)
LEFKOFSKY ERIC P — Director
Shares
6,890
Price
$51.52
Total Value
$354.97K
Shares Held After
8,841,783
% of Holdings
0.1%
Tempus AI, Inc. (TEM)
LEFKOFSKY ERIC P — Director
Shares
26,360
Price
$51.03
Total Value
$1.35M
Shares Held After
8,848,673
% of Holdings
0.3%
IRADIMED CORP (IRMD)
Susi Roger E. — Director
Shares
263
Price
$88.81
Total Value
$23.36K
Shares Held After
2,195,000
% of Holdings
0.0%
IRADIMED CORP (IRMD)
Susi Roger E. — Director
Shares
900
Price
$88.00
Total Value
$79.20K
Shares Held After
2,195,263
% of Holdings
0.0%
IRADIMED CORP (IRMD)
Susi Roger E. — Director
Shares
742
Price
$86.52
Total Value
$64.20K
Shares Held After
2,196,163
% of Holdings
0.0%
IRADIMED CORP (IRMD)
Susi Roger E. — Director
Shares
847
Price
$85.77
Total Value
$72.65K
Shares Held After
2,196,905
% of Holdings
0.0%
IRADIMED CORP (IRMD)
Susi Roger E. — Director
Shares
998
Price
$84.13
Total Value
$83.96K
Shares Held After
2,197,752
% of Holdings
0.0%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
95,412
Price
$0.73
Total Value
$69.65K
Shares Held After
2,010,508
% of Holdings
4.5%
Zenas BioPharma, Inc. (ZBIO)
MOULDER LEON O JR — Director
Shares
25,000
Price
$18.02
Total Value
$450.50K
Shares Held After
1,751,039
% of Holdings
1.4%
INTUITIVE SURGICAL INC (ISRG)
Ladd Amy L — Director
Shares
500
Price
$473.46
Total Value
$236.73K
Shares Held After
239
% of Holdings
67.7%
GILEAD SCIENCES, INC. (GILD)
O'Day Daniel Patrick — Director
Shares
3,050
Price
$130.01
Total Value
$396.53K
Shares Held After
632,567
% of Holdings
0.5%
GILEAD SCIENCES, INC. (GILD)
O'Day Daniel Patrick — Director
Shares
6,950
Price
$128.79
Total Value
$895.07K
Shares Held After
635,617
% of Holdings
1.1%
Kiniksa Pharmaceuticals International, plc (KNSA)
Quart Barry D — Director
Shares
13,099
Price
$50.10
Total Value
$656.26K
Shares Held After
12,546
% of Holdings
51.1%
MapLight Therapeutics, Inc. (MPLT)
GILLIS JONATHAN — CAAO and PAO
Shares
700
Price
$30.83
Total Value
$21.58K
Shares Held After
181,219
% of Holdings
0.4%
MapLight Therapeutics, Inc. (MPLT)
GILLIS JONATHAN — CAAO and PAO
Shares
17,235
Price
$30.33
Total Value
$522.74K
Shares Held After
181,919
% of Holdings
8.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
366
Price
$571.79
Total Value
$209.27K
Shares Held After
40,513
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
228
Price
$571.08
Total Value
$130.21K
Shares Held After
40,879
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
926
Price
$569.88
Total Value
$527.71K
Shares Held After
41,107
% of Holdings
2.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,531
Price
$568.93
Total Value
$871.04K
Shares Held After
42,033
% of Holdings
3.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,123
Price
$568.07
Total Value
$1.77M
Shares Held After
43,564
% of Holdings
6.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,489
Price
$567.01
Total Value
$844.28K
Shares Held After
46,687
% of Holdings
3.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,598
Price
$566.14
Total Value
$904.70K
Shares Held After
48,176
% of Holdings
3.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
239
Price
$565.18
Total Value
$135.08K
Shares Held After
49,774
% of Holdings
0.5%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
54
Price
$162.14
Total Value
$8.76K
Shares Held After
6,666
% of Holdings
0.8%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
89
Price
$161.72
Total Value
$14.39K
Shares Held After
6,720
% of Holdings
1.3%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
120
Price
$160.27
Total Value
$19.23K
Shares Held After
6,809
% of Holdings
1.7%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
380
Price
$159.42
Total Value
$60.58K
Shares Held After
6,929
% of Holdings
5.2%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
62
Price
$158.71
Total Value
$9.84K
Shares Held After
7,309
% of Holdings
0.8%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
222
Price
$157.49
Total Value
$34.96K
Shares Held After
7,371
% of Holdings
2.9%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
53
Price
$156.61
Total Value
$8.30K
Shares Held After
7,593
% of Holdings
0.7%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
8
Price
$155.36
Total Value
$1.24K
Shares Held After
7,646
% of Holdings
0.1%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
12
Price
$154.65
Total Value
$1.86K
Shares Held After
7,654
% of Holdings
0.2%
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
Heshmatpour Amir F — Director
Shares
10,000
Price
$4.52
Total Value
$45.18K
Shares Held After
3,062,000
% of Holdings
0.3%
Showing 401–450 of 1794 transactions (page 9 of 36)